Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 86Leukemia 50Gastrointestinal Stromal Tumors 41Leukemia, Myeloid, Chronic-Phase 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Blast Crisis 17Philadelphia Chromosome 13Brain Neoplasms 12Sarcoma 10Leukemia, Myeloid, Acute 10Glioblastoma 10Lung Neoplasms 9Leukemia, Myeloid, Accelerated Phase 9Gliosarcoma 9Prostatic Neoplasms 8Neoplasms 7Neoplasm Metastasis 7Glioma 7Oligodendroglioma 6Melanoma 6Leukemia, Myelomonocytic, Chronic 6Dermatofibrosarcoma 6Astrocytoma 6Small Cell Lung Carcinoma 5Recurrence 5Primary Myelofibrosis 5Polycythemia Vera 5Ovarian Neoplasms 5Leukemia, Myeloid 5Central Nervous System Neoplasms 5

Interventions

Letrozole 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anatomic Stage IV Breast Cancer AJCC v8 × Imatinib Mesylate × Clear all
NCT00338728 2020-01-27

Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
59 enrolled 7 charts
Breast

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡